Outcomes of Frozen Shoulder Treated With Small Needle-Knife Through Microcirculation and Pulse Analysis.
Outcomes of a Specially Designed Needle (Small Needle-Knife) Treating Frozen Shoulder Based on Analysis of Microcirculation and Pulse Changes
1 other identifier
interventional
120
0 countries
N/A
Brief Summary
The aim is to investigate whether adding small needle-knife therapy to standard Western medicine enhances the treatment of frozen shoulder by evaluating its impact on microcirculation and meridian unblocking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedNovember 18, 2023
November 1, 2023
1 year
November 14, 2023
November 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain VAS
The intensity of the pain along a continuum from 'no pain' to 'worst pain' imaginable with visual analog scale.
90 days
ROM
Glenohumeral range of motion(ROM) of the affected shoulder.
90 days
Secondary Outcomes (5)
WHOQOL-BREF
90 days
SPADI
90 days
LDF
90 days
BPW
90 days
PPG
90 days
Study Arms (2)
Small Needle-Knife
EXPERIMENTALThe small needle-knife (SNF) group undergoes rehabilitation treatment, with additional small needle-knife treatment once a week after acupuncture needle insertion at the Tiaokou (ST38) and Chengshan (BL57) acupoints. This treatment regimen will span over a duration of 3 weeks.
Standard treatment
ACTIVE COMPARATORRehabilitation treatment (based on the physician's assessment of the patient's clinical condition, using methods such as heat therapy, electrotherapy, manual therapy, or joint injections) at least once a week. This treatment regimen will span over a duration of 3 weeks.
Interventions
The small needle-knife therapy originated from the ancient Chinese acupuncture instrument known as the "Pi needle" from the "Nine Needles," which resembled a sword, had two sharp edges, and was originally used for abscess drainage. It is currently widely applied in treating conditions such as myofascial adhesions, chronic pain, or nerve compression. The small needle-knife features a flat and rounded tip design, with its handle made of solid steel. This construction provides excellent toughness and flexibility, minimizing tissue damage, and facilitating microadhesiolysis, an intervention aimed at releasing adhesions.
Eligibility Criteria
You may qualify if:
- Limited shoulder joint mobility in various angles (forward flexion, abduction, external rotation, and internal rotation), persisting for over two months.
- Persistent pain on the affected shoulder even without rest.
- Willing and consenting to participate in this research.
You may not qualify if:
- Degenerative shoulder joint arthritis (osteoarthritis).
- Rheumatoid arthritis.
- Fracture of the humerus, clavicle, scapula, shoulder acromioclavicular dislocation, shoulder dislocation.
- Cervical radiculopathy.
- Thoracic outlet syndrome.
- Restricted shoulder joint mobility due to stroke, spinal cord injury, or other factors.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Taipei City Hospitallead
- National Taiwan University of Science and Technologycollaborator
- National Yang Ming Chiao Tung Universitycollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ming Jen Wang, MD
Taipei City Hospital, Renai Branch, Chinese Medicine Department
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2023
First Posted
November 18, 2023
Study Start
January 1, 2024
Primary Completion
December 31, 2024
Study Completion
December 31, 2025
Last Updated
November 18, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share